Open AccessThe prevention and treatment of Covid-19 and related development during pandemic
Author(s) -
ChinKun Wang,
YuanTi Lee,
Chao-Bin Yeh,
CheeMing Chan
Publication year - 2021
Publication title -
journal of food bioactives
Language(s) - English
Resource type - Journals
eISSN - 2637-8779
pISSN - 2637-8752
DOI - 10.31665/jfb.2021.16290
Subject(s) - pandemic , covid-19 , outbreak , virology , medicine , drug development , coronavirus , intensive care medicine , disease , infectious disease (medical specialty) , drug , pharmacology , pathology
When the outbreak of human novel coronavirus was first reported in Wuhan, China at the end of 2019, the epidemic spread rapidly around the world and finally became a pandemic in 2020. In order to seek effective drugs to treat the Covid-19 infected patients for emergent use and for the disease prevention, researchers examined numerous existed antiviral drugs that may have the potential for Covid-19 treatment. At the same time, antibody treatment and vaccines development were ongoing simultaneously. The aim of this review is to introduce antibody therapy, vaccine development and potential antiviral treatments on Covid-19 and to discuss the future perspective on the Covid-19 pandemic.